Patents by Inventor Jae-Kyu Jung

Jae-Kyu Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20070072924
    Abstract: The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of ?-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
    Type: Application
    Filed: November 17, 2006
    Publication date: March 29, 2007
    Inventors: Graeme Semple, Thomas Schrader, Philip Skinner, Steven Colletti, Tawfik Gharbaoui, Jason Imbriglio, Jae-Kyu Jung, Rui Liang, Subharekha Raghavan, Darby Schmidt, James Tata
  • Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20070073062
    Abstract: The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like.
    Type: Application
    Filed: November 17, 2006
    Publication date: March 29, 2007
    Inventors: P. Boatman, Thomas Schrader, Graeme Semple, Philip Skinner, Jae-Kyu Jung
  • Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20060217562
    Abstract: The present invention relates to certain tetrazole derivatives of Formula (I), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of ?-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.
    Type: Application
    Filed: October 29, 2004
    Publication date: September 28, 2006
    Inventors: Graeme Semple, Thomas Schrader, Philip Skinner, Steven Colletti, Tawfik Gharbaoui, Jason Imbriglio, Jae-Kyu Jung, Rui Liang, Subharekha Raghavan, Darby Schmidt, James Tata
  • Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
    Publication number: 20060205955
    Abstract: The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like.
    Type: Application
    Filed: December 22, 2005
    Publication date: September 14, 2006
    Applicant: Arena Pharmaceuticals, Inc.
    Inventors: P. Boatman, Thomas Schrader, Graeme Semple, Philip Skinner, Jae-Kyu Jung